NCT04678167

Brief Summary

Vestibular neuritis is a brutal and continuous dizzying syndrome of peripheral (vestibular) origin without cochlear or other associated involvement. Specifically, vestibular neuritis is inflammation of the nerve that innervates the vestibular canals (the inner ear). It is characterized by the sudden onset of intense and prolonged vertigo accompanied by postural imbalance, nausea and vomiting, without hearing impairment or other neurological symptoms. Vestibular neuritis is the second cause of peripheral vertigo after benign paroxysmal positional vertigo. It represents approximately 7% of patients consulting for vertigo. The purpose of this study is to evaluate if wearing Boarding Ring glasses can be accelerated vestibular compensation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable

Timeline
36mo left

Started Mar 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Mar 2021May 2029

First Submitted

Initial submission to the registry

October 2, 2020

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 21, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

March 10, 2021

Completed
7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 17, 2028

Expected
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2029

Last Updated

March 19, 2026

Status Verified

March 1, 2026

Enrollment Period

7 years

First QC Date

October 2, 2020

Last Update Submit

March 18, 2026

Conditions

Keywords

vestibular hyporeflexiarotational vertigohorizontal-rotational nystagmus

Outcome Measures

Primary Outcomes (1)

  • Variation of the angle of deviation at the Fukuda test between J0 and J7 (value at J0 minus value at J7).

    7 day

Secondary Outcomes (8)

  • Speed of nystagmus

    1 year

  • Alexander's degree of nystagmus

    1 year

  • Duration of hospitalization (for hospitalized patients)

    1 year

  • Anxiety visual analog scale

    1 year

  • Handicap related to Balance Disorders and Vertigo scale (EHTEV questionnaire)

    1 year

  • +3 more secondary outcomes

Study Arms (3)

Boarding ring glasses

EXPERIMENTAL

Realization of the following examinations WITH Boarding ring glasses : * caloric tests, * measurement of the speed of Nystagmus, * angle of deviation in Fukuda, * Alexander's degree of nystagmus, * EHTEV and EEV questionnaires, * anxiety VAS

Diagnostic Test: Caloric testDiagnostic Test: Measurement of the speed of NystagmusDiagnostic Test: Angle of deviation at FukudaDiagnostic Test: Alexander's degree of nystagmusOther: EHTEV questionnaireOther: EEV questionnaireOther: anxiety VAS

Placebo glasses

PLACEBO COMPARATOR

Realization of the following examinations WITH Placebo glasses : * caloric tests, * measurement of the speed of Nystagmus, * angle of deviation in Fukuda, * Alexander's degree of nystagmus, * EHTEV and EEV questionnaires, * anxiety VAS

Diagnostic Test: Caloric testDiagnostic Test: Measurement of the speed of NystagmusDiagnostic Test: Angle of deviation at FukudaDiagnostic Test: Alexander's degree of nystagmusOther: EHTEV questionnaireOther: EEV questionnaireOther: anxiety VAS

No glasses

OTHER

Realization of the following examinations WITHOUT glasses : * caloric tests, * measurement of the speed of Nystagmus, * angle of deviation in Fukuda, * Alexander's degree of nystagmus, * EHTEV and EEV questionnaires, * anxiety VAS

Diagnostic Test: Caloric testDiagnostic Test: Measurement of the speed of NystagmusDiagnostic Test: Angle of deviation at FukudaDiagnostic Test: Alexander's degree of nystagmusOther: EHTEV questionnaireOther: EEV questionnaireOther: anxiety VAS

Interventions

A helmet with an infrared camera will be placed in front of patient eyes. This will allow visualizing on screen and measuring eye movements spontaneous or induced in the dark by various tests.

Boarding ring glassesNo glassesPlacebo glasses

The patient will be asked to trample on the spot (30 steps) with the indexes pointed forward. In the event of vestibular asymmetry, the patient turns at a varying angle to the right or to the left. This will then measure what is called the angle of deflection of the fukuda.

Boarding ring glassesNo glassesPlacebo glasses

there are 3 degrees: * Degree I: nystagmus that exists only when the eyes are turned to the right. * Degree II: also exists when the eyes are to the right or to the front. * Degree Ill: exists when the eyes are on the right, front, or left

Boarding ring glassesNo glassesPlacebo glasses

Handicap Scale for Balance Disorders and Vertigo

Boarding ring glassesNo glassesPlacebo glasses

European Vertigo Assessment Questionnaire

Boarding ring glassesNo glassesPlacebo glasses

visual analog scale of anxiety

Boarding ring glassesNo glassesPlacebo glasses
Caloric testDIAGNOSTIC_TEST

Lying, patientwill be placed so that he can introduce water (hot then cold) into his external ear canal. It is the reaction of the vestibular system (sensory organ responsible for balance) which is then measured with a helmet placed over his eyes and which measures the nystagmus (movement of the eye) which reflects vestibular activity.

Also known as: Barany test
Boarding ring glassesNo glassesPlacebo glasses

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adult patients,
  • patient with vestibular neuritis defined by appearance of continuous rotating vertigo with nausea
  • patient with spontaneous horizonto-rotating nystagmus beating towards the healthy ear
  • patient with a postural deviation towards the affected ear;
  • vestibular hyporeflexia measured at the caloric tests greater than 25%
  • patient who has given free, enlighten and written consent

You may not qualify if:

  • patient with a history of vertigo of vestibular origin or with vertigo developing for more than 4 days
  • patient with associated hearing loss or tinnitus
  • patient with an motor ocular abnormality of central origin
  • patient refusal or inability to consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CHU de Brest

Brest, 29200, France

RECRUITING

CH Pays de Morlaix

Morlaix, 29672, France

TERMINATED

MeSH Terms

Conditions

Vestibular Neuronitis

Interventions

Caloric Tests

Condition Hierarchy (Ancestors)

Vestibulocochlear Nerve DiseasesRetrocochlear DiseasesEar DiseasesOtorhinolaryngologic DiseasesCranial Nerve DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Vestibular Function TestsDiagnostic Techniques, OtologicalDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Jean-Christophe LECLERE, Dr

    University Hospital, Brest

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jean-Christophe LECLERE, Dr

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Only the investigator carrying out the follow-up consultations is blind. After examination by the ENT specialist (otorhinolaryngologist) who will diagnose vestibular neuritis, the patient will be randomized into one of three groups. The clinical follow-up will be performed by another practitioner, who will not know in which arm the patient is included (the patient will come to the consultation without his glasses). Only the practitioner who realized the randomization and the patient will have information about the arm in which they are located.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: The randomization list is established by the Brest CHRU data management unit before the start of the trial. Based on a ratio (1:1:1) with stratification on the center.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 2, 2020

First Posted

December 21, 2020

Study Start

March 10, 2021

Primary Completion (Estimated)

March 17, 2028

Study Completion (Estimated)

May 10, 2029

Last Updated

March 19, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

All collected data that underlie results in a publication

Shared Documents
STUDY PROTOCOL
Time Frame
Data will be available after the publication of result and ending fifteen years following the last visit of the last patient
Access Criteria
Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement.

Locations